SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-006027
Filing Date
2022-02-09
Accepted
2022-02-09 07:00:23
Documents
2
Period of Report
2022-02-09

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea155092-6k_purplebio.htm 6-K 17271
2 PURPLE BIOTECH REPORTS SECOND HALF AND FULL-YEAR 2021 FINANCIAL RESULTS ea155092ex99-1_purplebio.htm EX-99.1 339607
  Complete submission text file 0001213900-22-006027.txt   358105
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 22603765
SIC: 2834 Pharmaceutical Preparations